Healthtech Startups

MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support. It is intended for patients undergoing high-risk coronary interventions and those admitted with cardiogenic shock.

5 investors

Mahmee provides wraparound maternal and infant healthcare support through a team of nurses, doulas, lactation consultants, and mental health specialists, serving pregnant and postpartum families in the United States. The company aims to improve maternal health equity and reduce disparities in birth outcomes through comprehensive prenatal, birth, and postpartum care.

5 investors

Following a 2025 merger of Mallinckrodt and Endo, the combined business separated into two companies: Keenova Therapeutics, which develops treatments for rare, stigmatized, or unaddressed conditions across areas such as immunology, urology, hepatology, ophthalmology, orthopedics, and critical care; and Par Health, which produces generics, sterile injectables, and active pharmaceutical ingredients backed by a U.S.-based manufacturing network. The site serves as a landing page directing visitors to the two separate pharmaceutical companies.

5 investors

Manatee provides a mental health platform designed for families, offering care that addresses the needs of both children and parents. The platform aims to improve family connection and child resilience through modern, accessible mental health services.

5 investors

Materna Medical develops medical devices for women's pelvic health, including the FDA-cleared Milli vaginal dilator for treating vaginismus and painful intercourse, and the investigational Ellora System for labor support. The company serves women experiencing pelvic health challenges from conditions including menopause, postpartum recovery, cancer side effects, and sexual trauma.

5 investors

MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide therapeutics for endocrine and metabolic diseases. It applies expertise in peptide discovery and development to create precision peptide medicines aimed at improving treatment standards for these conditions.

5 investors

MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams. The platform serves healthcare organizations managing home-based clinical services, helping them optimize logistics, staffing, and scheduling workflows.

5 investors

Medefy is a mobile-first healthcare navigation platform that helps employers, brokers, TPAs, and public organizations guide members to appropriate care while reducing costs and improving health outcomes. The platform combines a mobile app with 24/7 live Care Guides to help users understand benefits, find in-network providers, and make informed healthcare decisions.

5 investors

MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds. Its products include NexoBrid, an approved therapy for severe thermal burns, and EscharEx, a candidate for debridement of chronic and hard-to-heal wounds, serving hospitalized and wound care patients worldwide.

5 investors

Medumo provides automated text and email messaging systems that guide patients through medical procedures and referrals for hospitals and surgical centers.

5 investors

Mightier develops technology to help children build emotional regulation and resilience skills. The company serves children and families through digital tools designed to improve emotional health and wellbeing.

5 investors

Mindbloom delivers guided ketamine therapy for depression and anxiety through a technology-enabled platform pairing clinicians with patients. The company serves individuals seeking science-backed mental health treatment in the United States.

5 investors

MiSalud provides digital health services to Spanish-speaking users, including personalized meal plans for weight management, chronic disease monitoring through telehealth with consistent doctor relationships, mental health programs for stress and anxiety, and access to discounted medications. The platform serves families seeking accessible healthcare and wellness support from home.

5 investors

Motivo provides clinical supervision and support services for newly graduated therapists entering the mental health workforce, helping behavioral health organizations address the shortage of qualified mental health providers.

5 investors

Naborforce connects older adults and their families to a vetted network of community members (Nabors) who provide caregiving support, companionship, and assistance. The platform addresses the needs of seniors and their families through technology-enabled neighborhood connections.

5 investors

Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke. The platform offers both one-time consultations and ongoing management care plans for patients seeking remote neurological care.

5 investors

NeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.

5 investors

Neurogastrx is a late clinical-stage biopharmaceutical company developing therapies for patients with serious gastrointestinal (GI) disorders that have limited treatment options. It focuses on identifying and advancing drug candidates for GI conditions, with a stated focus on the United States.

5 investors

Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder. Its device is powered by a discreet, wirelessly charged external battery worn daily, targeting patients—particularly women in the U.S.—affected by these conditions.

5 investors

Noah Medical develops the Galaxy System, a robotic bronchoscopy platform that integrates advanced imaging, precision targeting, and adaptive workflow for real-time lesion localization and lung diagnostics. The system is used by interventional pulmonologists and hospitals to improve diagnostic yield and accuracy.

5 investors

NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials. Its biodegradable formulas target animal health applications such as protecting hooves, horn buds and udders in farm environments, with active research collaborations with universities.

5 investors

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves. The company is advancing taplucainium inhalation powder, a first-in-class therapy in Phase 2b clinical development for refractory and unexplained chronic cough, with potential applications in pain, itch, and other conditions driven by neurogenic inflammation.

5 investors

NodThera develops clinical-stage small-molecule therapies targeting inflammation for cardiometabolic and neuroinflammatory diseases, including cardiovascular disease, metabolic dysfunction, and neuroinflammation. The company operates in the biotechnology and drug development sector.

5 investors

Nomi Health provides direct healthcare services and streamlines payment, claims, and contracts to reduce costs. The company serves patients and healthcare providers in the United States by eliminating healthcare system intermediaries.

5 investors